IP Library Granted Patent US 9,422,581
Granted Patent B2
US 9,422,581 · App. 13/840,649 · Granted Aug 23, 2016

Host cells and methods for production of isobutanol

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,422,581
App. No.
13/840,649
Granted
Aug 23, 2016
Kind
B2
Abstract

Provided herein are recombinant yeast host cells and methods for their use for production of isobutanol. Yeast host cells provided comprise an isobutanol biosynthetic pathway and at least one of reduced or eliminated aldehyde dehydrogenase activity, reduced or eliminated acetolactate reductase activity; or a heterologous polynucleotide encoding a polypeptide having ketol-acid reductoisomerase activity.

Claims (22)

1. A method for producing isobutanol comprising:

a) providing a recombinant yeast cell comprising:

(i) an engineered isobutanol production pathway comprising a heterologous polypeptide having ketol-acid reductoisomerase (KARI) activity wherein said polypeptide having KARI activity has at least 99% identity to the amino acid sequence set forth in SEQ ID NO:196;

(ii) a modification that eliminates expression or activity of a pyruvate decarboxylase polypeptide, wherein said modification is a deletion of an endogenous gene encoding said pyruvate decarboxylase polypeptide;

(iii) a modification that eliminates expression or activity of an NAD-dependent glycerol-3-phosphate dehydrogenase polypeptide, wherein said modification is a deletion of an endogenous gene encoding said NAD-dependent glycerol-3-phosphate dehydrogenase polypeptide; and

(iv) a modification that eliminates expression or activity of a polypeptide affecting Fe—S cluster biosynthesis in the yeast, wherein said modification is a deletion of an endogenous gene encoding said polypeptide affecting Fe—S cluster biosynthesis in the yeast; and

b) contacting said recombinant yeast cell of a) with a carbon substrate under conditions whereby isobutanol is produced.

2. The method of claim 1 , wherein said recombinant yeast cell further comprises a modification that eliminates expression or activity of an acetolactate reductase polypeptide in the yeast, wherein the modification is a deletion of an endogenous gene encoding said acetolactate reductase polypeptide.

3. The method of claim 1 , wherein said recombinant yeast cell further comprises a modification that eliminates expression or activity of an aldehyde dehydrogenase polypeptide in the yeast, wherein said modification is a deletion of an endogenous gene encoding said aldehyde dehydrogenase polypeptide.

4. The method of claim 3 , wherein said recombinant yeast cell further comprises a modification that eliminates the expression or activity of an acetolactate reductase polypeptide in the yeast, wherein the modification is a deletion of an endogenous gene encoding said acetolactate reductase polypeptide.

5. The method of claim 1 , wherein the isobutanol is removed as it is produced.

6. A method for producing isobutanol comprising:

a) providing a recombinant yeast cell comprising:

(i) an engineered isobutanol production pathway comprising a heterologous polypeptide having ketol-acid reductoisomerase (KARI) activity wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 196;

(ii) a modification that eliminates expression or activity of a pyruvate decarboxylase polypeptide, wherein said modification is a deletion of an endogenous gene encoding said pyruvate decarboxylase polypeptide;

(iii) a modification that eliminates expression or activity of an NAD-dependent glycerol-3-phosphate dehydrogenase polypeptide, wherein said modification is a deletion of an endogenous gene encoding said NAD-dependent glycerol-3-phosphate dehydrogenase polypeptide; and

(iv) a modification that eliminates expression or activity of a polypeptide affecting Fe—S cluster biosynthesis in the yeast, wherein said modification is a deletion of an endogenous gene encoding said polypeptide affecting Fe—S cluster biosynthesis in the yeast; and

b) contacting said recombinant yeast cell of a) with a carbon substrate under conditions whereby isobutanol is produced.

7. The method of claim 6 , wherein said recombinant yeast cell further comprises a modification that eliminates expression or activity of an acetolactate reductase polypeptide in the yeast, wherein the modification is a deletion of an endogenous gene encoding said acetolactate reductase polypeptide.

8. The method of claim 6 , wherein said recombinant yeast cell further comprises a modification that eliminates expression or activity of an aldehyde dehydrogenase polypeptide in the yeast, wherein said modification is a deletion of an endogenous gene encoding said aldehyde dehydrogenase polypeptide.

9. The method of claim 8 , wherein said recombinant yeast cell further comprises a modification that eliminates the expression or activity of an acetolactate reductase polypeptide in the yeast, wherein the modification is a deletion of an endogenous gene encoding said acetolactate reductase polypeptide.

10. The method of claim 6 , wherein the isobutanol is removed as it is produced.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2016
From: ANTHONY, LARRY CAMERON; HE, HONGXIAN; HUANG, LIXUAN LISA; O'KEEFE, DANIEL P.; KRUCKEBERG, ARTHUR LEO; LI, YOUGEN; MAGGIO-HALL, LORI ANN; MCELVAIN, JESSICA; NELSON, MARK J.; PATNAIK, RANJAN; ROTHMAN, STEVEN CARY
To: BUTAMAX(TM) ADVANCED BIOFUELS LLC
Reel/Frame 038592/0078 →